NIAGARA FALLS, March 16, 2016 – Compounding pharmacist, JENNIFER M. SCHOENHALS, RPh, BSc. Phm, BBA, PharmD, of FALLS PHARMACY, has achieved the professional rating of Hormone Replacement Therapy Specialist by completing a rigorous program of study, Comprehensive Core Concepts in Compounding, offered by PCCA. The course includes specialized study of ovarian anatomy, physiology and endogenous hormone function, laboratory tests and uses, clinical compounded treatment therapies, dosing guidelines and patient counseling.
Hormone Replacement Therapy (HRT) is a growing practice in pharmacy compounding, in which specialized pharmacists prepare customized medications for patients, by prescription order, when a practitioner determines that an off-the-shelf medication is not appropriate for the patient. HRT is most often prescribed to ease the symptoms of menopause, but it also can be used to treat a variety of conditions that women of all ages may experience, including:
These conditions affect millions of women. As the number of women seeking hormone-related treatment has grown, so has the mass production of pills, patches and creams by the drug industry. However, each woman’s body is different and has its own unique needs, but commercially manufactured products tend to be “one-size-fits-all,” and do not always account for the differences between individuals.